Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by hamster, mouse and rat intestine: Relevance of species differences

Carcinogenesis

Volumn 17, Issue 5, 1996, Pages 1093-1099

  Schulze, J ^a   Schlager W ^a   Wunsch R ^a   Richter, E ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ACETONE; CARBON 14; CARCINOGEN; ISOTHIOCYANIC ACID DERIVATIVE; OXOACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HAMSTER; HYDROXYLATION; INTESTINE; JEJUNUM; MALE; METABOLISM; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE; STARVATION;

ANIMALS; CARCINOGENS; CRICETINAE; FEMALE; INTESTINES; MALE; MESOCRICETUS; MICE; NITROSAMINES; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; SPECIES SPECIFICITY;

EID: 0029941167     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.5.1093     Document Type: Article

References (45)

1. Hecht,S.S. (1994) Metabolic activation and detoxification of tobacco-specific nitrosamines - a model for cancer prevention strategies. Drug Metab. Rev., 26, 373-390.
2. Fischer,S., Spiegelhalder,B., Eisenbarth,J. and Preussmann,R. (1990) Investigations on the origin of tobacco-specific nitrosamines in mainstream smoke of cigarettes. Carcinogenesis, 11, 723-730.
3. Idris,A.M., Nair,J., Friesen,M., Ohshima,H., Brouet,I., Faustman,E.M. and Bartsch,H. (1992) Carcinogenic tobacco-specific nitrosamines are present at unusually high levels in the saliva of oral snuff users in Sudan. Carcinogenesis, 13, 1001-1005.
4. Prokopzcyk,B., Wu,M., Cox,J.E., Amin,A., Desai,D., Idris,A.M. and Hoffmann,D. (1995) Improved methodology for the quantitative assessment of tobacco-specific N-nitrosamines in tobacco by supercritical fluid extraction. J. Agric. Food Chem., 43, 916-922
5. Wynder,E.L. and Hoffmann,D. (1994) Smoking and lung cancer: scientific challenges and opportunities. Cancer Res., 54, 5284-5295
6. Muir,C.S. and Zaridze,D.G. (1986) Smokeless tobacco and cancer: an overview. In Zaridze,D. and Peto,R. (eds), Tobacco - A Major International Health Hazard. IARC Scientific Publication no. 74, IARC, Lyon, France pp. 35-44.
7. Morse,M.A., Eklind,K.I., Touissant,M., Amin,S.G. and Chung,F.-L. (1990) Characterization of a glucuronide metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its dose-dependent excretion in the urine of mice and rats. Carcinogenesis, 11, 1819-1823.
8. Hecht,S.S. et al. (1993) Metabolism of the tobacco-specific nitrosamine 4-methylnitrosamino-1-(3-pyridyl)-1-butanone in the Patas monkey: pharmacokinetics and characterization of glucuronide metabolites. Carcinogenesis, 14, 229-236
9. Richter,E. and Tricker,A.R. (1994) Nicotine inhibits the metabolic activation of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats. Carcinogenesis, 15, 1061-1064.
10. Desai,D., Kagan,S.S., Amin,S., Carmella,S.G. and Hecht,S.S. (1993) Identification of 4-(methylnitrosamino)-1-[3-(6-hydroxypyridyl)]-1-butanone as a urinary metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rodents. Chem. Res. Toxicol., 6, 794-799.
11. Castonguay,A., Lin,D., Stoner,G.D., Radok,P., Furuya,K., Hecht,S.S., Schut,H.A.J. and Klaunig,J.E. (1983) Comparative carcinogenicity in A/J-mice and metabolism by cultured mouse peripheral lung of N-nitrosonornicotine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and their analogues. Cancer Res., 43, 1223-1229.
12. Guo,Z., Smith,T.J., Wang,E., Eklind,K.I., Chung,F.L. and Yang,C.S. (1993) Structure-activity relationships of arylalkyl isothiocyanates for the inhibition of 4-(methylnitrosamino)-1-(3pyridyl)-1-butanone metabolism and the modulation of xenobiotic-metabolizing enzymes in rats and mice. Carcinogenesis, 14, 1167-1173.
13. Hong,J.-Y. Wang,Z.Y., Smith,T.J., Zhou,S.Z., Shi,S., Pan,J. and Yang,C.S. (1992) Inhibitory effects of diallyl sulfide on the metabolism and tumorigemcity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A/J mouse lung. Carcinogenesis. 13, 901-904.
14. Guo,Z., Smith,T.J., Wang,E., Sadrieh,N., Ma,Q., Thomas,P.E. and Yang,C.S. (1992) Effects of phenethylisothiccyanate, a Carcinogenesis inhibitor, on xenobiotic-metabolizing enzymes, and nitrosamine metabolism in rats. Carcinogenesis, 13, 2205-2210.
15. Jorquera,R., Castonguay,A. and Schuller,H.M. (1992) Effect of pregnancy and ethanol treatment on the metabolism of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone by hamster liver and lung microsomes. Drug Metab. Dispos., 20, 510-517.
16. Jorquera,R., Castonguay,A. and Schuller,H.M. (1993) Effect of tobacco smoke condensate on the metabolism of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone by adult and fetal hamster microsomes. Drug Metab. Dispos., 21, 318-324.
17. Smith,T.J., Guo,Z., Gonzalez,F.J., Guengerich,F.P., Stoner,G.D. and Yang,C.S. (1992) Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells. Cancer Res., 52, 1757-1763.
18. Smith,T.J., Guo,Z., Hong,J.-Y. Ning,S.M., Thomas,P.E. and Yang,C.S. (1992) Kinetics and enzyme involvement in the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butancme (NNK) in microsomes and its inhibition by isothiocyanates. Carcinogenesis, 13, 1409-1414.
19. Schulze,J., Malone,A. and Richter,E. (1995) Intestinal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in rats: sexdifference, inducibility and inhibition by phenethylisothiocyanate. Carcinogenesis, 16, 1733-1740.
20. Schulze J., Hunder,G. and Richter,E. (1990) Intestinal first pass metabolism of NNK in the mouse. In Adlkofer,F. and Thurau,K. (eds), Advances in Pharmacological Sciences: Effects of Nicotine on Biological Systems. Birkhäuser, Basel, Switzerland, pp. 123-127.
21. Pepin,P., Bouchard,L., Nicole,P. and Castonguay,A. (1992) Effects of sulindac and oltipraz on the tumorigenicity of 4-(methylnitrosamino)-1 - (3-pyridyl)-1-butanone in A/J mouse lung. Carcinogenesis, 13, 341-348.
22. Correa,E., Joshi,P.A., Castonguay,A. and Schuller,H.M. (1990) The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is an active transplacental carcinogen in Syrian golden hamsters. Cancer Res., 50, 3435-3438.
23. Schuller,H.M., Lu,X.-C., Reichert,A. and Castonguay,A. (1992) Transplacental carcinogenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) at low dose levels in the hamster. Proc. Am. Ass. Cancer Res., 33, 113.
24. Schuller,H.M., Jorquera,R., Reichert,A. and Castonguay,A. (1993) Transplacental induction of pancreas tumors in hamsters by ethanol and the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res., 53, 2498-2501.
25. Kaminsky,L.S. and Fasco,M. (1992) Small intestinal cytochrome P450. Crit. Rev. Toxicol., 21, 407-422.
26. Richter,E. and Strugala,G.J. (1985) All-glass perfusator for investigation of the intestinal transport and metabolism of foreign compounds in vitro. J. Pharmacol. Methods, 14, 297-304.
27. Richter,E., Richter-Cooberg,U., Feng,X., Schulze,J. and Wiessler,M. (1986) Intestinal metabolism of nitrosamines. 1. Transport and metabolism of six nitrosamines in isolated perfused rat small intestinal segments. Carcinogenesis, 7, 1207-1213.
28. Richter,E., Zwickenpflug,W. and Wiessler,M. (1988) Intestinal first pass metabolism of nitrosamines. 2. Metabolism of N-nitrosodibutylamine in isolated perfused rat small intestinal segments. Carcinogenesis, 9, 499-506.
29. Richter,E., Lorck,C. and Wiessler,M. (1988) Intestinal first pass metabolism of nitrosamines. 3. Identification of metabolites of N-nitrosodiamylamine. Carcinogenesis, 9, 507-509
30. Morse,M.A., Eklind,K.I., Amin,S.G., Hecht,S.S. and Chung,F.-L. (1989) Effects of alkyl chain length on the inhibition of NNK induced lung neoplasia in A/J mice by aralkyl isothiocyanates. Carcinogenesis, 10, 1757-1759.
31. Morse,M.A., Wang,X.-A., Stoner,G.D., Mandal,S., Conran,P.B., Amin, S.G., Hecht,S.S. and Chung,F.-L. (1989) Inhibition of 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA adduct formation and tumorigenicity in the lung of F344 rats by phenethyl isothiocyanates. Cancer Res., 49, 549-553
32. Smith,T.J., Guo,Z., Li,C., Ning,S.M., Thomas,P.E. and Yang,C.S. (1993) Mechanisms of inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation by dietary phenethyl isothiocyanate. Cancer Res., 53, 3276-3282.
33. Carmella,S.G. and Hecht,S.S. (1987) Formation of hemoglobin adducts upon treatment of F344 rats with the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitrosonornicotine. Cancer Res., 47, 2626-2630.
34. Schulze,J., Richter,E., Binder,U. and Zwickenpflug,W. (1992) Biliary excretion of 4-methylnitrosamino-(3-pyridyl)-1-butanone in the rat. Carcinogenesis, 13, 1961-1965
35. Rivenson,A., Hoffmann,D., Prokopzcyk,B., Amin,S. and Hecht,S.S. (1988) Induction of lung and exocrine pancreas tumors in F344 rats by tobaccospecific and areca nut-derived N-nitrosamines. Cancer Res., 48, 6912-6917
36. Hoffmann,D., Rivenson,A., Abbi,R. and Wynder,E.L. (1993) A study of tobacco Carcinogenesis - effect of the fat content of the diet on the carcinogenic activity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. Cancer Res., 53, 2758-2761.
37. Furukawa,F., Nishikawa,A., Yoshimura,H., Mitsui.M., Imazawa,T., Ikezaki,S. and Takahashi,M. (1994) Effects of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) on N-nitrosobis(2-oxopropyl)amine (BOP)-initiated Carcinogenesis in hamsters. Cancer Lett., 86, 75-82.
38. Yang,C.S., Brady,J.F. and Hong,J.Y. (1992) Dietary effects on cytochromesP450, xenobiotic metabolism, and toxicity. FASEB J., 6, 737-744
39. Traber,P.G., ChianaleJ., Florence,R., Kim,K., Wojcik,E. and Gumucio,J.J. (1988) Expression of cytochrome P450b and P450e genes in small intestinal mucosa of rats following treatment with phenobarbital, polyhalogenated biphenyls, and organochlorine pesticides. J. Biol. Chem., 263, 9449-9455
40. Traber,P.G., Wang,W. and Yu,L. (1992) Differential regulation of cytochromes P-450 genes along rat intestinal crypt-villus axis. Am. J. Physiol., 263, G215-G233.
41. Thorgeirsson,U.P., Dalgard,D.W., Reeves,J. and Adamson,R.H. (1994) Tumor incidence in a chemical carcinogenesis study of nonhuman primates. Regulat. Toxicol. Pharmacol., 19, 130-151.
42. Perzin,K.H., Peterson,M., Castiglione,C.L., Fenoglio,D.M. and Wolff,M. (1984) Intramucosal carcinoma of the small intestine arising in regional enteriitis (Crohn's disease). Report of a case studied for carcinoembryonic antigen and review of the literature. Cancer, 54, 151-162.
43. Adams,J.D., LaVoie,E.J., O'Mara-Adams,K.J., Hoffmann,D., Carey,K.D. and Marshall,M.V. (1985) Pharmacokinetics of N-nitrosonornicotine and 4-methylnitrosamino-1-(3-pyridyl)-1-butanone in laboratory animals. Cancer Lett., 28, 195-201.
44. Atawodi,S.E.O., Michelsen,K. and Richter,E. (1994) Metabolism of a glucuronide conjugate of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone in rats. Arch. Toxicol., 69, 14-17.
45. Smith,T.J., Guo,Z., Li,C., Ning,S.M., Thomas,P.E. and Yang,C.S. (1993) Mechanisms of inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation by dietary phenethyl isothiocyanate. Cancer Res., 53, 3276-3282.